These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33078630)

  • 21. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?
    Dall'Ara F; Frassi M; Tincani A; Airò P
    Clin Rheumatol; 2016 Aug; 35(8):2117-2123. PubMed ID: 26758435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.
    Cipriani P; Ruscitti P; Carubbi F; Pantano I; Liakouli V; Berardicurti O; Giacomelli R
    Clin Rheumatol; 2014 Jan; 33(1):49-55. PubMed ID: 24005839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs.
    Ruscitti P; McGonagle D; Garcia VC; Rabijns H; Toennessen K; Chappell M; Edwards M; Miller P; Hansell N; Moss J; Graziadio S; Feist E
    J Rheumatol; 2024 May; 51(5):442-451. PubMed ID: 38302170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence.
    de Boysson H; Février J; Nicolle A; Auzary C; Geffray L
    Clin Rheumatol; 2013 Jan; 32(1):141-7. PubMed ID: 23108887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review.
    Cota-Arce JM; Cota J; De León-Nava MA; Hernández-Cáceres A; Moncayo-Salazar LI; Valle-Alvarado F; Cordero-Moreno VL; Bonfil-Solis KL; Bichara-Figueroa JE; Hernández-Hernández J; Villela L
    Semin Arthritis Rheum; 2021 Dec; 51(6):1282-1290. PubMed ID: 34493394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canakinumab for the treatment of adult-onset Still's disease.
    Sfriso P; Bindoli S; Doria A; Feist E; Galozzi P
    Expert Rev Clin Immunol; 2020 Feb; 16(2):129-138. PubMed ID: 31957508
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients.
    Bodard Q; Langlois V; Guilpain P; Le Quellec A; Vittecoq O; Noel D; Eble V; Josse S; Schmidt J; Aouba A; Levesque H; Le Besnerais M; Benhamou Y
    J Autoimmun; 2021 Jan; 116():102541. PubMed ID: 32943282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.
    Kadavath S; Efthimiou P
    Ann Med; 2015 Feb; 47(1):6-14. PubMed ID: 25613167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.
    Maranini B; Ciancio G; Govoni M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease.
    Kontzias A; Efthimiou P
    Semin Arthritis Rheum; 2012 Oct; 42(2):201-5. PubMed ID: 22512815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
    Guignard S; Dien G; Dougados M
    Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.
    Perdan-Pirkmajer K; Praprotnik S; Tomšič M
    Clin Rheumatol; 2010 Dec; 29(12):1465-7. PubMed ID: 20734215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.
    Thonhofer R; Hiller M; Just H; Trummer M; Siegel C; Dejaco C
    Rheumatol Int; 2011 Dec; 31(12):1653-6. PubMed ID: 21240503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult-onset Still's disease: clinical, serological and therapeutic considerations.
    Iliou C; Papagoras C; Tsifetaki N; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2013; 31(1):47-52. PubMed ID: 23010097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
    Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
    Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of refractory adult-onset Still's disease treated with anakinra.
    Lahiri M; Teng GG
    Int J Rheum Dis; 2010 Aug; 13(3):e36-41. PubMed ID: 20704609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.